[تقرير بحثي] من المتوقع أن ينمو سوق العلاج بالتسريب المنزلي من 21,765.95 مليون دولار أمريكي في عام 2022 إلى 35,696.05 مليون دولار أمريكي بحلول عام 2028؛ ومن المقدر أن يسجل معدل نمو سنوي مركب يبلغ 8.6% من عام 2022 إلى عام 2028.
رؤى السوق وعرض المحللين:
يتضمن العلاج بالتسريب المنزلي إعطاء أدوية أو مواد بيولوجية عن طريق الوريد أو تحت الجلد للفرد في المنزل. تشمل المكونات اللازمة لإجراء التسريب المنزلي الدواء (الأدوية المضادة للفيروسات، والجلوبيولين المناعي)، والمعدات (المضخة)، والإمدادات (الأنابيب والقسطرة). تتطلب عملية التسريب المنزلي عادةً التنسيق بين كيانات متعددة، بما في ذلك المرضى والأطباء ومخططي الخروج من المستشفى والخطط الصحية وصيدليات التسريب المنزلي، ووكالات الصحة المنزلية، إن أمكن. تعمل تزايد حالات الاضطرابات المزمنة وارتفاع عدد كبار السن على تعزيز نمو سوق العلاج بالتسريب المنزلي.
محركات النمو والتحديات:
تؤثر الاضطرابات المزمنة مثل اضطرابات القلب والأوعية الدموية، واضطرابات التغذية، والجهاز الهضمي، والتهاب المفاصل الروماتويدي، والاضطرابات العصبية على نوعية الحياة بشكل عام. وفقاً لمنظمة الصحة العالمية، تشير التقديرات إلى أن أكثر من 50% من سكان العالم يعانون من مرض مزمن واحد على الأقل. ذكرت مراكز السيطرة على الأمراض والوقاية منها (CDC) أن 6 من كل 10 أشخاص في الولايات المتحدة عانوا من مرض مزمن واحد على الأقل في عام 2019. وفقًا لـ "انتشار وعبء اضطرابات الجهاز الهضمي الوظيفية في جميع أنحاء العالم، نتائج الدراسة العالمية لمؤسسة روما". "،" في دراسة متعددة الجنسيات واسعة النطاق نُشرت في عام 2021، كان حوالي 40% من 73,076 بالغًا شملهم الاستطلاع من 33 دولة في العالم يعانون من اضطراب الجهاز الهضمي الوظيفي (GFID). تعد مشاكل الجهاز الهضمي المرتبطة بالعمر أكثر شيوعًا لدى كبار السن، الذين تبلغ أعمارهم 64 عامًا فما فوق. وفقًا للدراسة التي تحمل عنوان "مشكلة الجهاز الهضمي بين البالغين الهنود: أدلة من دراسة الشيخوخة الطولية في الهند"، والتي نُشرت في عام 2022، تم الإبلاغ عن انتشار اضطرابات الجهاز الهضمي المبلغ عنها ذاتيًا بنسبة 18٪ تقريبًا. تشير الدراسة أيضًا إلى أنه تم ملاحظة معدلات متفاوتة من مشاكل الجهاز الهضمي في جميع أنحاء العالم، تتراوح من 14% في إيران إلى 54% في بعض الدول الغربية.
أمراض القلب والأوعية الدموية (CVDs) ، وخاصة الحالات المرتبطة بأنماط الحياة المحمومة، هي سبب كبير للوفيات على مستوى العالم. وفقًا للاتحاد الدولي للسكري (IDF)، أصيب 537 مليون شخص في جميع أنحاء العالم، تتراوح أعمارهم بين 20 و79 عامًا، بمرض السكري في عام 2021، ومن المتوقع أن يرتفع العدد إلى 783 مليونًا بحلول عام 2045. بالإضافة إلى ذلك، كان مرض السكري سببًا لـ 6.7 مليون حالة وفاة في جميع أنحاء العالم في عام 2019. 2021. وفقًا لتحالف الأعصاب، تم تسجيل ما يقرب من 14.7 مليون حالة عصبية في عام 2019، حيث يعاني شخص واحد على الأقل من كل 6 أشخاص من حالة عصبية واحدة أو أكثر.
يمكن أن تسبب الشيخوخة فقدان مستمر للسلامة الفسيولوجية، مما يؤدي إلى انخفاض في الأداء الوظيفي وزيادة خطر الوفاة. يعد تدهور وظائف الجسم عامل خطر رئيسي للإصابة بأغلبية الأمراض المزمنة، بما في ذلك مرض السكري، والأمراض القلبية الوعائية، والأمراض العصبية، بين المرضى المسنين. وفقًا للمسح العالمي للشيخوخة لعام 2019، من المرجح أن يرتفع عدد الأشخاص الذين يبلغون من العمر 65 عامًا أو أكثر من 1 من كل 11 نسمة في عام 2019 إلى 1 من كل 6 سكان بحلول عام 2025. ووفقًا لمكتب الإحصاء الأمريكي، فإن عدد الأمريكيين الذين لديهم ومن المتوقع أن يتضاعف عدد الأشخاص الذين تبلغ أعمارهم 65 عامًا فما فوق من 46 مليونًا في عام 2016 إلى أكثر من 98 مليونًا بحلول عام 2060، وستزداد حصة كبار السن من سكان العالم من 15% إلى 24% تقريبًا في نفس الفترة. علاوة على ذلك، باستثناء أفريقيا، ستكون وتيرة الشيخوخة مرتفعة في جميع المناطق، حيث سيكون ما يقرب من ربع سكانها أو أكثر في سن 60 عاما أو أكثر بحلول عام 2050. وبالتالي، فإن ارتفاع معدلات الإصابة بالأمراض المزمنة، إلى جانب تزايد عدد السكان المسنين، يدفع نمو سوق العلاج بالتسريب المنزلي.
ومع ذلك، في السنوات القليلة الماضية، تلقت الوكالات الطبية العديد من التقارير عن الأحداث السلبية التي تنطوي على مضخات التسريب والتي أدت إلى سحب المنتجات. السبب الرئيسي لاسترجاع منتجات مضخة التسريب هو المشكلات المتعلقة بالبرمجيات، ومشكلات واجهة المستخدم، والأعطال الميكانيكية والكهربائية. على سبيل المثال، في أبريل 2022، استدعت شركة سميثس ميديكال أكثر من 118000 مضخة ضخ حقنة Medfusion (الطرازين 3500 و4000) بسبب خلل في البرمجيات، مما تسبب في ضرر جسيم للمريض أو الوفاة بسبب نقص التسريب أو الإفراط فيه، أو تأخير تسليم الأدوية المهمة إلى المرضى. مرضى. وأدى إلى إصابة سبعة أشخاص بجروح خطيرة ووفاة واحدة. وبالمثل، في ديسمبر 2020، أعلنت إدارة الغذاء والدواء الأمريكية عن سحب الفئة الأولى لأكثر من نصف مليون مضخة تسريب من شركة باكستر سيجما بسبب عيب في الإنذار تسبب في وفاة 3 مرضى وإصابة 51 إصابة خطيرة. وبالتالي، فإن المخاوف المتعلقة بالسلامة المرتبطة بإجراءات التسريب في المنزل وعمليات سحب مضخات التسريب تعيق نمو سوق العلاج بالتسريب في المنزل.
رؤى إستراتيجية
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed to perform home infusion include the drug (antivirals, immune globulin), equipment (a pump), and supplies (tubing and catheters). The home infusion process typically requires coordination among multiple entities, including patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if applicable, home health agencies.
Key factors driving the market growth are increasing incidences of chronic disorders coupled with rising geriatric population and reduction in duration of hospital stays and surge in cost of care.
Based on product, the home infusion therapy market is segmented into infusion pump, intravenous sets, IV cannulas, and needleless connectors. The market for the infusion pumps segment is subsegmented into insulin pumps, elastomeric pumps, syringe pumps, and others. The infusion pumps segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period.
Based on application, the home infusion therapy market is segmented into enteral nutrition, anti-infective, endocrinology, hydration therapy, chemotherapy, specialty pharmaceuticals, and others. The anti-infective segment held the largest share of the market in 2021. The endocrinology segment is expected to record the highest CAGR during the forecast period.
Global home infusion therapy market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the home infusion therapy market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.
Companies operating in the market are B. Braun Melsungen AG, Micrel Medical Devices SA, Baxter International Inc, Nipro Corp, Becton Dickinson and Co, Fresenius Kabi AG, ICU Medical Inc, JMS Co Ltd, Eitan Medical Ltd, and Terumo Corp.
The List of Companies - Home Infusion Therapy Market:
- B. Braun Melsungen AG
- Micrel Medical Devices SA
- Baxter International Inc
- Nipro Corp
- Becton Dickinson and Co
- Fresenius Kabi AG
- ICU Medical Inc
- JMS Co Ltd
- Eitan Medical Ltd
- Terumo Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2023
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Feb 2023
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Feb 2023
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)